JG6, a novel marine-derived oligosaccharide, suppresses breast cancer metastasis via binding to cofilin

Xun Huang; Danni Sun; Qiuming Pan; Weiwei Wen; Yi Chen; Xianliang Xin; Min Huang; Jian Ding; Meiyu Geng

doi:10.18632/oncotarget.1959

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

JG6, a novel marine-derived oligosaccharide, suppresses breast cancer metastasis via binding to cofilin

Xun Huang, Danni Sun, Qiuming Pan, Weiwei Wen, Yi Chen, Xianliang Xin, Min Huang, Jian Ding and Meiyu Geng _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2014; 5:3568-3578. https://doi.org/10.18632/oncotarget.1959

Metrics: PDF 2582 views | HTML 4713 views | ?

Abstract

Xun Huang1,*, Danni Sun1,*, Qiuming Pan1, Weiwei Wen1, Yi Chen1, Xianliang Xin1, Min Huang1, Jian Ding1 and Meiyu Geng1

1 Division of Anti-Tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, P.R.China

* These authors contributed equally to this work

Correspondence:

Meiyu Geng,, email:

Jian Ding, email:

Keywords: JG6, cofilin, actin, migration, metastasis

Received: February 25, 2014 Accepted: May 12, 2014 Published: May 12, 2014

Abstract

Cofilin, an actin-binding protein which disassembles actin filaments, plays an important role in invasion and metastasis. Here, we discover that JG6, an oligomannurarate sulfate, binds to cofilin, suppresses the migration of human breast cancer cells and cancer metastasis in breast cancer xenograft model. Mechanistically, JG6 occupies actin-binding sites of cofilin, thereby disrupting cofilin modulated actin turnover. Our results highlight the significance of cofilin in cancer and suggest JG6, a cofilin inhibitor, to treat metastatic cancer.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 1959

Publication Alerts

Research Papers:

JG6, a novel marine-derived oligosaccharide, suppresses breast cancer metastasis via binding to cofilin

Abstract